研究等業績 - その他 - 齋藤 雅也
-
糖尿病性腎症患者の末梢血単核球におけるToll-like receptor(TLR)2、4 mRNA発現と臨床組織学的検討
齋藤 綾乃, 加賀 一, 齋藤 雅也, 奈良 瑞穂, 小松田 敦, 涌井 秀樹, 高橋 直人
日本腎臓学会誌 ( (一社)日本腎臓学会 ) 59 ( 3 ) 292 - 292 2017年04月
-
DISTRIBUTION PATTERN OF GLOMERULAR IGG SUBCLASS DEPOSITS IN MEMBRANOUS NEPHROPATHY PATIENTS WITH CRESCENT FORMATION AND POSITIVE MPO-ANCA
Masaya Saitoh, Atsushi Komatsuda, Yuhta Oyama, Masato Sawamura, Masatoyo Ozawa, Hideki Wakui, Naoto Takahashi
RHEUMATOLOGY ( OXFORD UNIV PRESS ) 56 138 - 138 2017年03月
-
ANCA-ASSOCIATED VASCULITIS COMPLICATING WITH LARGE VESSEL INVOLVEMENT AND HYPERTROPHIC PACHYMENINGITIS: REPORT OF AN AUTOPSY CASE AND REVIEW OF THE LITERATURE
Hajime Kaga, Atsushi Komatsuda, Masaya Saitoh, Mizuho Nara, Ayumi Omokawa, Masaru Togashi, Shin Okuyama, Hideki Wakui, Naoto Takahashi
RHEUMATOLOGY ( OXFORD UNIV PRESS ) 56 70 - 70 2017年03月
-
Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging
Mizuho Nara, Atsushi Komatsuda, Fumiko Itoh, Hajime Kaga, Masaya Saitoh, Masaru Togashi, Yoshihiro Kameoka, Hideki Wakui, Naoto Takahashi
INTERNAL MEDICINE ( JAPAN SOC INTERNAL MEDICINE ) 56 ( 10 ) 1247 - 1252 2017年
Thrombocytopenia, Anasarca, Fever, Reticulin fibrosis/Renal failure, and Organomegaly (TAFRO) syndrome is a recently described systemic inflammatory disorder characterized by thrombocytopenia, anasarca, fever, reticulin fibrosis/renal failure, and organomegaly. It has an acute or subacute onset of unknown etiology, although some pathological features resemble those of multicentric Castleman disease. We here report two cases of TAFRO syndrome. The symptoms and pathological findings in these cases met the 2015 diagnostic criteria. Our cases showed high serum procalcitonin levels, suggesting bacterial infection as an onset trigger. In addition, Case 1 is the first case complicated with adrenal hemorrhaging. Case 2 is the second case of tocilizumab-resistant TAFRO syndrome successfully treated with rituximab.